AMYRA Biotech AG is a leader in the development of innovative solutions to support and enhance the digestive capabilities of enzymes lining the small intestine. AMYRA’s Brush Border Enzyme Supplementation Technology (BBEST) pipeline addresses general health and nutrition, food sensitivities, and gastrointestinal diseases. The lead product in AMYRA’s BBEST pipeline, AMYNOPEP01, is the first and only synergistic combination of exopeptidases, enzymes specifically designed to completely digest protein fragments into easily absorbed amino acids.   
AMYRA is based in Basel, Switzerland.

AMYRA Biotech AG

Org chart

Teams

Offices